Literature DB >> 22900886

Role of the PD-1 pathway in the immune response.

L V Riella1, A M Paterson, A H Sharpe, A Chandraker.   

Abstract

Understanding immunoregulatory mechanisms is essential for the development of novel interventions to improve long-term allograft survival. Programmed death 1 (PD-1) and its ligands, PD-L1 and PD-L2, have emerged as critical inhibitory signaling pathways that regulate T cell response and maintain peripheral tolerance. PD-1 signaling inhibits alloreactive T cell activation, and can promote induced regulatory T cell development. Furthermore, the upregulation of PD-L1 on nonhematopoietic cells of the allograft may actively participate in the inhibition of immune responses and provide tissue-specific protection. In murine transplant models, this pathway has been shown to be critical for the induction and maintenance of graft tolerance. In this review, we discuss the current knowledge of the immunoregulatory functions of PD-1 and its ligands and their therapeutic potential in transplantation. © Copyright 2012 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22900886      PMCID: PMC3784243          DOI: 10.1111/j.1600-6143.2012.04224.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  126 in total

1.  B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance.

Authors:  Jang-June Park; Ryusuke Omiya; Yumiko Matsumura; Yukimi Sakoda; Atsuo Kuramasu; Mathew M Augustine; Sheng Yao; Fumihiko Tsushima; Hidehiko Narazaki; Sudarshan Anand; Yingjia Liu; Scott E Strome; Lieping Chen; Koji Tamada
Journal:  Blood       Date:  2010-05-14       Impact factor: 22.113

2.  Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection.

Authors:  Elias A Said; Franck P Dupuy; Lydie Trautmann; Yuwei Zhang; Yu Shi; Mohamed El-Far; Brenna J Hill; Alessandra Noto; Petronela Ancuta; Yoav Peretz; Simone G Fonseca; Julien Van Grevenynghe; Mohamed R Boulassel; Julie Bruneau; Naglaa H Shoukry; Jean-Pierre Routy; Daniel C Douek; Elias K Haddad; Rafick-Pierre Sekaly
Journal:  Nat Med       Date:  2010-03-07       Impact factor: 53.440

3.  Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia.

Authors:  Qing Zhou; Meghan E Munger; Steven L Highfill; Jakub Tolar; Brenda J Weigel; Megan Riddle; Arlene H Sharpe; Daniel A Vallera; Miyuki Azuma; Bruce L Levine; Carl H June; William J Murphy; David H Munn; Bruce R Blazar
Journal:  Blood       Date:  2010-06-22       Impact factor: 22.113

4.  Renal tubular PD-L1 (CD274) suppresses alloreactive human T-cell responses.

Authors:  Astrid Starke; Maja T Lindenmeyer; Stephan Segerer; Matthias A Neusser; Barbara Rüsi; Daniel M Schmid; Clemens D Cohen; Rudolf P Wüthrich; Thomas Fehr; Ying Waeckerle-Men
Journal:  Kidney Int       Date:  2010-04-14       Impact factor: 10.612

5.  Host APCs augment in vivo expansion of donor natural regulatory T cells via B7H1/B7.1 in allogeneic recipients.

Authors:  Tangsheng Yi; Xiaofan Li; Sheng Yao; Lin Wang; Yuhong Chen; Dongchang Zhao; Heather F Johnston; James S Young; Hongjun Liu; Ivan Todorov; Stephen J Forman; Lieping Chen; Defu Zeng
Journal:  J Immunol       Date:  2011-01-24       Impact factor: 5.422

6.  Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates.

Authors:  Julie R Brahmer; Charles G Drake; Ira Wollner; John D Powderly; Joel Picus; William H Sharfman; Elizabeth Stankevich; Alice Pons; Theresa M Salay; Tracee L McMiller; Marta M Gilson; Changyu Wang; Mark Selby; Janis M Taube; Robert Anders; Lieping Chen; Alan J Korman; Drew M Pardoll; Israel Lowy; Suzanne L Topalian
Journal:  J Clin Oncol       Date:  2010-06-01       Impact factor: 44.544

7.  Follicular helper T cell differentiation requires continuous antigen presentation that is independent of unique B cell signaling.

Authors:  Elissa K Deenick; Anna Chan; Cindy S Ma; Dominique Gatto; Pamela L Schwartzberg; Robert Brink; Stuart G Tangye
Journal:  Immunity       Date:  2010-08-05       Impact factor: 31.745

Review 8.  The PD-1 pathway in tolerance and autoimmunity.

Authors:  Loise M Francisco; Peter T Sage; Arlene H Sharpe
Journal:  Immunol Rev       Date:  2010-07       Impact factor: 12.988

9.  Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero.

Authors:  Jeff E Mold; Jakob Michaëlsson; Trevor D Burt; Marcus O Muench; Karen P Beckerman; Michael P Busch; Tzong-Hae Lee; Douglas F Nixon; Joseph M McCune
Journal:  Science       Date:  2008-12-05       Impact factor: 47.728

10.  PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells.

Authors:  Kim L Good-Jacobson; Courtney G Szumilas; Lieping Chen; Arlene H Sharpe; Mary M Tomayko; Mark J Shlomchik
Journal:  Nat Immunol       Date:  2010-05-09       Impact factor: 25.606

View more
  130 in total

1.  Computational Redesign of PD-1 Interface for PD-L1 Ligand Selectivity.

Authors:  Rojan Shrestha; Sarah C Garrett; Steven C Almo; Andras Fiser
Journal:  Structure       Date:  2019-03-28       Impact factor: 5.006

2.  IL-7 receptor blockade following T cell depletion promotes long-term allograft survival.

Authors:  Hoa-Le Mai; Françoise Boeffard; Julie Longis; Richard Danger; Bernard Martinet; Fabienne Haspot; Bernard Vanhove; Sophie Brouard; Jean-Paul Soulillou
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

3.  Increased numbers of circulating ICOS⁺ follicular helper T and CD38⁺ plasma cells in patients with newly diagnosed primary biliary cirrhosis.

Authors:  Li Wang; Xiguang Sun; Jinpeng Qiu; Yanjun Cai; Liang Ma; Pingwei Zhao; Yanfang Jiang
Journal:  Dig Dis Sci       Date:  2014-11-18       Impact factor: 3.199

4.  Myeloid-derived suppressor cells impair alveolar macrophages through PD-1 receptor ligation during Pneumocystis pneumonia.

Authors:  Guang-Sheng Lei; Chen Zhang; Chao-Hung Lee
Journal:  Infect Immun       Date:  2014-11-17       Impact factor: 3.441

5.  IL-15 temporally reorients IL-10 biased B-1a cells toward IL-12 expression.

Authors:  Amlan Kanti Ghosh; Debolina Sinha; Subhadeep Mukherjee; Ratna Biswas; Tapas Biswas
Journal:  Cell Mol Immunol       Date:  2015-03-09       Impact factor: 11.530

Review 6.  T-cell exhaustion in allograft rejection and tolerance.

Authors:  Edward B Thorp; Christian Stehlik; M Javeed Ansari
Journal:  Curr Opin Organ Transplant       Date:  2015-02       Impact factor: 2.640

7.  Epigenetic Remodeling in Exhausted T Cells: Implications for Transplantation Tolerance.

Authors:  Sonia J Laurie; Mandy L Ford
Journal:  Transplantation       Date:  2017-05       Impact factor: 4.939

8.  Characterization of soluble PD-L1 in pleural effusions of mesothelioma patients: potential implications in the immune response and prognosis.

Authors:  Roberta Carosio; Vincenzo Fontana; Luca Mastracci; Paola Ferro; Federica Grillo; Barbara Banelli; Pier Aldo Canessa; Paolo Dessanti; Antonella Vigani; Anna Morabito; Ulrich Pfeffer; Alessandro Poggi; Silvio Roncella; Maria Pia Pistillo
Journal:  J Cancer Res Clin Oncol       Date:  2020-11-20       Impact factor: 4.553

9.  Follicular helper T cells: new insights into mechanisms of autoimmune diseases.

Authors:  Xin Zhang; Sharon Ing; Austin Fraser; Minzi Chen; Omar Khan; Jerald Zakem; William Davis; Robert Quinet
Journal:  Ochsner J       Date:  2013

10.  Impaired selectin-dependent leukocyte recruitment induces T-cell exhaustion and prevents chronic allograft vasculopathy and rejection.

Authors:  Bara Sarraj; Junsheng Ye; Ahmed Ibrahim Akl; Guodong Chen; Jiao-Jing Wang; Zheng Zhang; Farida Abadja; Michael Abecassis; Stephen D Miller; Geoffrey S Kansas; M Javeed Ansari
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.